Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

[Atopic dermatitis - current insights into path physiology and management].

Schmid-Grendelmeier P, Ballmer-Weber BK.

Ther Umsch. 2010 Apr;67(4):175-85. doi: 10.1024/0040-5930/a000031. Review. German.

PMID:
20336617
2.

Atopic eczema: genetics or environment?

Wüthrich B, Cozzio A, Roll A, Senti G, Kündig T, Schmid-Grendelmeier P.

Ann Agric Environ Med. 2007;14(2):195-201. Review.

3.

What's new in atopic eczema?

Plötz SG, Ring J.

Expert Opin Emerg Drugs. 2010 Jun;15(2):249-67. doi: 10.1517/14728211003792518. Review.

PMID:
20433363
4.

What is new in atopic dermatitis/eczema?

Plötz SG, Wiesender M, Todorova A, Ring J.

Expert Opin Emerg Drugs. 2014 Dec;19(4):441-58. doi: 10.1517/14728214.2014.953927. Epub 2014 Oct 7. Review.

PMID:
25286776
5.

[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].

Gliński W, Kruszewski J, Silny W, Kurzawa R, Czarnecka-Operacz M, Baran E, Szepietowski J; Task Force of the National Specialists on Dermatology, Venereology and Allergology.

Pol Merkur Lekarski. 2004;17 Suppl 3:3-15. Review. Polish.

PMID:
15688665
6.

Therapy of atopic eczema.

Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.

GMS Health Technol Assess. 2006 Oct 6;2:Doc19.

7.

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN).

J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1045-60. doi: 10.1111/j.1468-3083.2012.04635.x.

PMID:
22805051
8.

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network.

J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-93. doi: 10.1111/j.1468-3083.2012.04636.x. Epub 2012 Jul 19. Review.

PMID:
22813359
9.

Atopic dermatitis: an update and review of the literature.

Lipozencić J, Wolf R.

Dermatol Clin. 2007 Oct;25(4):605-12, x. Review.

PMID:
17903619
10.

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.

Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema Task Force.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub 2009 Aug 31. Review.

PMID:
19732254
11.

Etiopathogenesis of atopic dermatitis--an overview.

Pastar Z, Lipozencić J, Ljubojević S.

Acta Dermatovenerol Croat. 2005;13(1):54-62.

PMID:
15788148
12.

Atopic dermatitis: an overview.

Berke R, Singh A, Guralnick M.

Am Fam Physician. 2012 Jul 1;86(1):35-42. Review.

13.

[Constitutional eczema; the possibilities of local treatment].

Sillevis Smitt JH.

Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):400-4. Review. Dutch.

PMID:
11901940
14.
15.
16.

The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.

Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L.

Health Technol Assess. 2005 Jul;9(29):iii, xi-xiii,1-230. Review.

17.

[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].

de Bruin-Weller MS, Bruijnzeel-Koomen CA.

Ned Tijdschr Geneeskd. 2005 May 14;149(20):1096-100. Review. Dutch.

PMID:
15932135
18.

The role of sensitization to Malassezia sympodialis in atopic eczema.

Schmid-Grendelmeier P, Scheynius A, Crameri R.

Chem Immunol Allergy. 2006;91:98-109. Review.

PMID:
16354952
19.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.

Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.

J Dermatolog Treat. 2005 Aug;16(3):142-8.

PMID:
16096179
20.

Management of itch in atopic dermatitis.

Hong J, Buddenkotte J, Berger TG, Steinhoff M.

Semin Cutan Med Surg. 2011 Jun;30(2):71-86. doi: 10.1016/j.sder.2011.05.002. Review.

Supplemental Content

Support Center